Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas.
AJNR Am J Neuroradiol. 2016 Nov;37(11):2003-2009. doi: 10.3174/ajnr.A4866. Epub 2016 Jul 7.
AJNR Am J Neuroradiol. 2016.
PMID: 27390321
Free article.